300158 振东制药
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)0.449-0.843-0.76938.1434.729
总资产报酬率 ROA (%)0.380-0.691-0.61629.5813.610
投入资产回报率 ROIC (%)0.433-0.807-0.72834.6704.229

边际利润分析
销售毛利率 (%)44.39350.37549.31459.66762.234
营业利润率 (%)4.128-0.827-0.15961.2826.729
息税前利润/营业总收入 (%)3.905-1.3030.12661.4577.042
净利润/营业总收入 (%)2.857-1.320-1.52951.2325.231

收益指标分析
经营活动净收益/利润总额(%)-42.001401.7133,667.0272.70079.911
价值变动净收益/利润总额(%)63.040-119.491-1,250.83394.8034.332
营业外收支净额/利润总额(%)-4.18320.453-12.118-0.175-1.041

偿债能力分析
流动比率 (X)5.3434.8644.0384.6802.237
速动比率 (X)3.9013.5603.1504.1591.753
资产负债率 (%)15.07716.76920.26620.2010.259
带息债务/全部投入资本 (%)1.5031.2112.8934.0749.563
股东权益/带息债务 (%)6,405.7107,972.6533,282.5432,314.544903.707
股东权益/负债合计 (%)567.214499.702395.756396.256286.540
利息保障倍数 (X)-68.0334.9400.471218.05418.409

营运能力分析
应收账款周转天数 (天)73.08166.03076.49971.14582.872
存货周转天数 (天)240.664227.064191.597154.396139.506